Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary : Global Antihypertensive Drugs Market


4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Antihypertensive Drugs Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)


5. Market Outlook

5.1. Key Industry Developments

5.2. Regulatory Scenario

5.3. Reimbursement Scenario

5.4. Key Mergers & Acquisitions

5.5. Technological Advancements


6. Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Drug

6.1. Introduction & Definition

6.2. Global Antihypertensive Drugs Market Value Forecast, by Drug, 2017–2027

6.2.1. Diuretics

6.2.1.1. Thiazide Diuretics

6.2.1.2. Loop Diuretics

6.2.1.3. Potassium-sparing Diuretics

6.2.2. Angiotensin Converting Enzyme Inhibitors

6.2.3. Angiotensin Receptor Blockers

6.2.4. Beta-blockers

6.2.4.1. Beta-1 Selective

6.2.4.2. Intrinsic Sympathomimetic

6.2.5. Vasodilators

6.2.6. Calcium Channel Blockers

6.2.7. Renin Inhibitors

6.2.8. Alpha-blockers

6.2.9. Others

6.3. Global Antihypertensive Drugs Market Attractiveness, by Drug


7. Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Condition

7.1. Introduction & Definition

7.2. Global Antihypertensive Drugs Market Value Forecast, by Condition, 2017–2027

7.2.1. Primary Hypertension

7.2.2. Secondary Hypertension

7.3. Global Antihypertensive Drugs Market Attractiveness, by Condition


8. Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Medication Type

8.1. Introduction

8.2. Global Antihypertensive Drugs Market Value Forecast, by Medication Type, 2017–2027

8.2.1. Monotherapy

8.2.2. Combination Therapy

8.2.3. Fixed Dose Combinations

8.3. Global Antihypertensive Drugs Market Attractiveness, by Medication Type


9. Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Distribution Channel

9.1. Introduction

9.2. Global Antihypertensive Drugs Market Value Forecast, by Distribution Channel, 2017–2027

9.2.1. Retail Pharmacies

9.2.2. Hospital Pharmacies

9.2.3. Online Pharmacies

9.2.4. Others

9.3. Global Antihypertensive Drugs Market Attractiveness, by Distribution Channel


10. Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Region

10.1. Introduction

10.2. Antihypertensive Drugs Market Value Forecast, by Region, 2017–2027

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Global Antihypertensive Drugs Market Attractiveness, by Region


11. North America Antihypertensive Drugs Market Analysis and Forecast

11.1. Introduction

11.2. North America Antihypertensive Drugs Market Value Forecast, by Drug, 2017–2027

11.2.1. Diuretics

11.2.1.1. Thiazide Diuretics

11.2.1.2. Loop Diuretics

11.2.1.3. Potassium-sparing Diuretics

11.2.2. Angiotensin Converting Enzyme Inhibitors

11.2.3. Angiotensin Receptor Blockers

11.2.4. Beta-blockers

11.2.4.1. Beta-1 Selective

11.2.4.2. Intrinsic Sympathomimetic

11.2.5. Vasodilators

11.2.6. Calcium Channel Blockers

11.2.7. Renin Inhibitors

11.2.8. Alpha-blockers

11.2.9. Others

11.3. North America Antihypertensive Drugs Market Value Forecast, by Condition, 2017–2027

11.3.1. Primary Hypertension

11.3.2. Secondary Hypertension

11.4. North America Antihypertensive Drugs Market Value Forecast, by Medication Type, 2017–2027

11.4.1. Monotherapy

11.4.2. Combination Therapy

11.4.3. Fixed Dose Combinations

11.4.4. Others

11.5. North America Antihypertensive Drugs Market Value Forecast, by Distribution Channel, 2017–2027

11.5.1. Retail Pharmacies

11.5.2. Hospital Pharmacies

11.5.3. Online Pharmacies

11.5.4. Others

11.6. North America Antihypertensive Drugs Market Value Forecast, by Country, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. North America Antihypertensive Drugs Market Attractiveness Analysis

11.7.1. By Drug

11.7.2. By Condition

11.7.3. By Medication Type

11.7.4. By Distribution Channel

11.7.5. By Country


12. Europe Antihypertensive Drugs Market Analysis and Forecast

12.1. Introduction

12.2. Europe Antihypertensive Drugs Market Value Forecast, by Drug, 2017–2027

12.2.1. Diuretics

12.2.1.1. Thiazide Diuretics

12.2.1.2. Loop Diuretics

12.2.1.3. Potassium-sparing Diuretics

12.2.2. Angiotensin Converting Enzyme Inhibitors

12.2.3. Angiotensin Receptor Blockers

12.2.4. Beta-blockers

12.2.4.1. Beta-1 Selective

12.2.4.2. Intrinsic Sympathomimetic

12.2.5. Vasodilators

12.2.6. Calcium Channel Blockers

12.2.7. Renin Inhibitors

12.2.8. Alpha-blockers

12.2.9. Others

12.3. Europe Antihypertensive Drugs Market Value Forecast, by Condition, 2017–2027

12.3.1. Primary Hypertension

12.3.2. Secondary Hypertension

12.4. Europe Antihypertensive Drugs Market Value Forecast, by Medication Type, 2017–2027

12.4.1. Monotherapy

12.4.2. Combination Therapy

12.4.3. Fixed Dose Combinations

12.4.4. Others

12.5. Europe Antihypertensive Drugs Market Value Forecast, by Distribution Channel, 2017–2027

12.5.1. Retail Pharmacies

12.5.2. Hospital Pharmacies

12.5.3. Online Pharmacies

12.5.4. Others

12.6. Europe Antihypertensive Drugs Market Value Forecast, by Country/Sub-region, 2017–2027

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Europe Antihypertensive Drugs Market Attractiveness Analysis

12.7.1. By Drug

12.7.2. By Condition

12.7.3. By Medication Type

12.7.4. By Distribution Channel

12.7.5. By Country/Sub-region

13. Asia Pacific Antihypertensive Drugs Market Analysis and Forecast

13.1. Introduction

13.2. Asia Pacific Antihypertensive Drugs Market Value Forecast, by Drug, 2017–2027

13.2.1. Diuretics

13.2.1.1. Thiazide Diuretics

13.2.1.2. Loop Diuretics

13.2.1.3. Potassium-sparing Diuretics

13.2.2. Angiotensin Converting Enzyme Inhibitors

13.2.3. Angiotensin Receptor Blockers

13.2.4. Beta-blockers

13.2.4.1. Beta-1 Selective

13.2.4.2. Intrinsic Sympathomimetic

13.2.5. Vasodilators

13.2.6. Calcium Channel Blockers

13.2.7. Renin Inhibitors

13.2.8. Alpha-blockers

13.2.9. Others

13.3. Asia Pacific Antihypertensive Drugs Market Value Forecast, by Condition, 2017–2027

13.3.1. Primary Hypertension

13.3.2. Secondary Hypertension

13.4. Asia Pacific Antihypertensive Drugs Market Value Forecast, by Medication Type, 2017–2027

13.4.1. Monotherapy

13.4.2. Combination Therapy

13.4.3. Fixed Dose Combinations

13.4.4. Others

13.5. Asia Pacific Antihypertensive Drugs Market Value Forecast, by Distribution Channel, 2017–2027

13.5.1. Retail Pharmacies

13.5.2. Hospital Pharmacies

13.5.3. Online Pharmacies

13.5.4. Others

13.6. Asia Pacific Antihypertensive Drugs Market Value Forecast, by Country/Sub-region, 2017–2027

13.6.1. Japan

13.6.2. China

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Asia Pacific Antihypertensive Drugs Market Attractiveness Analysis

13.7.1. By Drug

13.7.2. By Condition

13.7.3. By Medication Type

13.7.4. By Distribution Channel

13.7.5. By Country/Sub-region


14. Latin America Antihypertensive Drugs Market Analysis and Forecast

14.1. Introduction

14.2. Latin America Antihypertensive Drugs Market Value Forecast, by Drug, 2017–2027

14.2.1. Diuretics

14.2.1.1. Thiazide Diuretics

14.2.1.2. Loop Diuretics

14.2.1.3. Potassium-sparing Diuretics

14.2.2. Angiotensin Converting Enzyme Inhibitors

14.2.3. Angiotensin Receptor Blockers

14.2.4. Beta-blockers

14.2.4.1. Beta-1 Selective

14.2.4.2. Intrinsic Sympathomimetic

14.2.5. Vasodilators

14.2.6. Calcium Channel Blockers

14.2.7. Renin Inhibitors

14.2.8. Alpha-blockers

14.2.9. Others

14.3. Latin America Antihypertensive Drugs Market Value Forecast, by Condition, 2017–2027

14.3.1. Primary Hypertension

14.3.2. Secondary Hypertension

14.4. Latin America Antihypertensive Drugs Market Value Forecast, by Medication Type, 2017–2027

14.4.1. Monotherapy

14.4.2. Combination Therapy

14.4.3. Fixed Dose Combinations

14.4.4. Others

14.5. Latin America Antihypertensive Drugs Market Value Forecast, by Distribution Channel, 2017–2027

14.5.1. Retail Pharmacies

14.5.2. Hospital Pharmacies

14.5.3. Online Pharmacies

14.5.4. Others

14.6. Latin America Antihypertensive Drugs Market Value Forecast, by Country/Sub-region, 2017–2027

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Latin America Antihypertensive Drugs Market Attractiveness Analysis

14.7.1. By Drug

14.7.2. By Condition

14.7.3. By Medication Type

14.7.4. By Distribution Channel

14.7.5. By Country/Sub-region


15. Middle East & Africa Antihypertensive Drugs Market Analysis and Forecast

15.1. Introduction

15.2. Middle East & Africa Antihypertensive Drugs Market Value Forecast, by Drug, 2017–2027

15.2.1. Diuretics

15.2.1.1. Thiazide Diuretics

15.2.1.2. Loop Diuretics

15.2.1.3. Potassium-sparing Diuretics

15.2.2. Angiotensin Converting Enzyme Inhibitors

15.2.3. Angiotensin Receptor Blockers

15.2.4. Beta-blockers

15.2.4.1. Beta-1 Selective

15.2.4.2. Intrinsic Sympathomimetic

15.2.5. Vasodilators

15.2.6. Calcium Channel Blockers

15.2.7. Renin Inhibitors

15.2.8. Alpha-blockers

15.2.9. Others

15.3. Middle East & Africa Antihypertensive Drugs Market Value Forecast, by Condition, 2017–2027

15.3.1. Primary Hypertension

15.3.2. Secondary Hypertension

15.4. Middle East & Africa Antihypertensive Drugs Market Value Forecast, by Medication Type, 2017–2027

15.4.1. Monotherapy

15.4.2. Combination Therapy

15.4.3. Fixed Dose Combinations

15.4.4. Others

15.5. Middle East & Africa Antihypertensive Drugs Market Value Forecast, by Distribution Channel, 2017–2027

15.5.1. Retail Pharmacies

15.5.2. Hospital Pharmacies

15.5.3. Online Pharmacies

15.5.4. Others

15.6. Middle East & Africa Antihypertensive Drugs Market Value Forecast, by Country/Sub-region, 2017–2027

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Israel

15.6.4. Rest of Middle East & Africa

15.7. Middle East & Africa Antihypertensive Drugs Market Attractiveness Analysis

15.7.1. By Drug

15.7.2. By Condition

15.7.3. By Medication Type

15.7.4. By Distribution Channel

15.7.5. By Country/Sub-region


16. Competition Landscape

16.1. Global Antihypertensive Drugs Market Share Analysis, by Company (2018)

16.2. Company Profiles

16.2.1. Pfizer Inc.

16.2.1.1. Company Description

16.2.1.2. Business Overview

16.2.1.3. Financial Overview

16.2.1.4. Strategic Overview

16.2.1.5. SWOT Analysis

16.2.2. Sanofi S.A

16.2.2.1. Company Description

16.2.2.2. Business Overview

16.2.2.3. Financial Overview

16.2.2.4. Strategic Overview

16.2.2.5. SWOT Analysis

16.2.3. Novartis AG

16.2.3.1. Company Description

16.2.3.2. Business Overview

16.2.3.3. Financial Overview

16.2.3.4. Strategic Overview

16.2.3.5. SWOT Analysis

16.2.4. Boehringer Ingelheim GmbH

16.2.4.1. Company Description

16.2.4.2. Business Overview

16.2.4.3. Financial Overview

16.2.4.4. Strategic Overview

16.2.4.5. SWOT Analysis

16.2.5. Actelion Ltd. (Johnson & Johnson Services, Inc.)

16.2.5.1. Company Description

16.2.5.2. Business Overview

16.2.5.3. Financial Overview

16.2.5.4. Strategic Overview

16.2.5.5. SWOT Analysis

16.2.6. F. Hoffmann-La Roche Ltd.

16.2.6.1. Company Description

16.2.6.2. Business Overview

16.2.6.3. Financial Overview

16.2.6.4. Strategic Overview

16.2.6.5. SWOT Analysis

16.2.7. Bayer AG

16.2.7.1. Company Description

16.2.7.2. Business Overview

16.2.7.3. Financial Overview

16.2.7.4. Strategic Overview

16.2.7.5. SWOT Analysis

16.2.8. Daiichi Sankyo Company, Limited

16.2.8.1. Company Description

16.2.8.2. Business Overview

16.2.8.3. Financial Overview

16.2.8.4. Strategic Overview

16.2.8.5. SWOT Analysis

16.2.9. Takeda Pharmaceutical Company Limited

16.2.9.1. Company Description

16.2.9.2. Business Overview

16.2.9.3. Financial Overview

16.2.9.4. Strategic Overview

16.2.9.5. SWOT Analysis



List of Figures



Figure 01: Global Antihypertensive Drugs Market Value (US$ Mn) Forecast and Distribution (%), by Region, 2019 and 2027

Figure 02: Antihypertensive Drugs Market – Key Industry Developments

Figure 03: Market Drivers

Figure 04: Market Restraints

Figure 05: Key Opportunities

Figure 06: Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, 2017–2027

Figure 07: Global Antihypertensive Drugs Market Value Share (%), by Drug (2018)

Figure 08: Global Antihypertensive Drugs Market Value Share (%), by Condition (2018)

Figure 09: Global Antihypertensive Drugs Market Value Share (%), by Medication Type (2018)

Figure 10: Global Antihypertensive Drugs Market Value Share (%), by Distribution Channel (2018)

Figure 11: Europe Regulatory Approval Process

Figure 12: Technological Advancements

Figure 13: Global Antihypertensive Drugs Market Value Share (%), by Drug, 2018 and 2027

Figure 14: Global Antihypertensive Drugs Market Attractiveness, by Drug, 2019–2027

Figure 15: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diuretics, 2017–2027

Figure 16: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Angiotensin Converting Enzyme Inhibitors, 2017–2027

Figure 17: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vasodilators, 2017–2027

Figure 18: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Calcium Channel Blockers, 2017–2027

Figure 19: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 20: Global Antihypertensive Drugs Market Value Share (%), by Condition, 2018 and 2027

Figure 21: Global Antihypertensive Drugs Market Attractiveness, by Condition, 2019–2027

Figure 22: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Secondary Hypertension, 2017–2027

Figure 23: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Primary Hypertension, 2017–2027

Figure 24: Global Antihypertensive Drugs Market Value Share (%), by Medication Type, 2018 and 2027

Figure 25: Global Antihypertensive Drugs Market Attractiveness, by Medication Type, 2019–2027

Figure 26: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Monotherapy, 2017–2027

Figure 27: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fixed Dose Combinations, 2017–2027

Figure 28: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 29: Global Antihypertensive Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 30: Global Antihypertensive Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 31: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2027

Figure 32: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 33: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017–2027

Figure 34: Global Antihypertensive Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2027

Figure 35: Global Antihypertensive Drugs Market: Regional Outlook

Figure 36: Global Antihypertensive Drugs Market Value Share (%), by Region, 2018 and 2027

Figure 37: Global Antihypertensive Drugs Market Attractiveness Analysis, by Region, 2019–2027

Figure 38: North America Antihypertensive Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 39: North America Antihypertensive Drugs Market Value Share Analysis, by Country, 2018 and 2027

Figure 40: North America Antihypertensive Drugs Market Attractiveness Analysis, by Country, 2019–2027

Figure 41: North America Antihypertensive Drugs Market Value Share (%), by Drug, 2018 and 2027

Figure 42: North America Antihypertensive Drugs Market Attractiveness, by Drug, 2019–2027

Figure 43: North America Antihypertensive Drugs Market Value Share (%), by Condition, 2018 and 2027

Figure 44: North America Antihypertensive Drugs Market Attractiveness, by Condition, 2019–2027

Figure 45: North America Antihypertensive Drugs Market Value Share (%), by Medication Type, 2018 and 2027

Figure 46: North America Antihypertensive Drugs Market Attractiveness, by Medication Type, 2019–2027

Figure 47: North America Antihypertensive Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 48: North America Antihypertensive Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 49: Europe Antihypertensive Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 50: Europe Antihypertensive Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 51: Europe Antihypertensive Drugs Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 52: Europe Antihypertensive Drugs Market Value Share (%), by Drug, 2018 and 2027

Figure 53: Europe Antihypertensive Drugs Market Attractiveness, by Drug, 2019–2027

Figure 54: Europe Antihypertensive Drugs Market Value Share (%), by Medication Type, 2018 and 2027

Figure 55: Europe Antihypertensive Drugs Market Attractiveness, by Medication Type, 2019–2027

Figure 56: Europe Antihypertensive Drugs Market Value Share (%), by Condition, 2018 and 2027

Figure 57: Europe Antihypertensive Drugs Market Attractiveness, by Condition, 2019–2027

Figure 58: Europe Antihypertensive Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 59: Europe Antihypertensive Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 60: Asia Pacific Antihypertensive Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 61: Asia Pacific Antihypertensive Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 62: Asia Pacific Antihypertensive Drugs Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 63: Asia Pacific Antihypertensive Drugs Market Value Share (%), by Drug, 2018 and 2027

Figure 64: Asia Pacific Antihypertensive Drugs Market Attractiveness, by Drug, 2019–2027

Figure 65: Asia Pacific Antihypertensive Drugs Market Value Share (%), by Condition, 2018 and 2027

Figure 66: Asia Pacific Antihypertensive Drugs Market Attractiveness, by Condition, 2019–2027

Figure 67: Asia Pacific Antihypertensive Drugs Market Value Share (%), by Medication Type, 2018 and 2027

Figure 68: Asia Pacific Antihypertensive Drugs Market Attractiveness, by Medication Type, 2019–2027

Figure 69: Asia Pacific Antihypertensive Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 70: Asia Pacific Antihypertensive Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 71: Latin America Antihypertensive Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 72: Latin America Antihypertensive Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 73: Latin America Antihypertensive Drugs Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 74: Latin America Antihypertensive Drugs Market Value Share (%), by Drug, 2018 and 2027

Figure 75: Latin America Antihypertensive Drugs Market Attractiveness, by Drug, 2019–2027

Figure 76: Latin America Antihypertensive Drugs Market Value Share (%), by Condition, 2018 and 2027

Figure 77: Latin America Antihypertensive Drugs Market Attractiveness, by Condition, 2019–2027

Figure 78: Latin America Antihypertensive Drugs Market Value Share (%), by Medication Type, 2018 and 2027

Figure 79: Latin America Antihypertensive Drugs Market Attractiveness, by Medication Type, 2019–2027

Figure 80: Latin America Antihypertensive Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 81: Latin America Antihypertensive Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 82: Middle East & Africa Antihypertensive Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 83: Middle East & Africa Antihypertensive Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 84: Middle East & Africa Antihypertensive Drugs Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 85: Middle East & Africa Antihypertensive Drugs Market Value Share (%), by Drug, 2018 and 2027

Figure 86: Middle East & Africa Antihypertensive Drugs Market Attractiveness, by Drug, 2019–2027

Figure 87: Middle East & Africa Antihypertensive Drugs Market Value Share (%), by Condition, 2018 and 2027

Figure 88: Middle East & Africa Antihypertensive Drugs Market Attractiveness, by Condition, 2019–2027

Figure 89: Middle East & Africa Antihypertensive Drugs Market Value Share (%), by Medication Type, 2018 and 2027

Figure 90: Middle East & Africa Antihypertensive Drugs Market Attractiveness, by Medication Type, 2019–2027

Figure 91: Middle East & Africa Antihypertensive Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 92: Middle East & Africa Antihypertensive Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 93: Global Antihypertensive Drugs Market Share Analysis, by Company (2018)

 

List of Tables



Table 01: Hospital Inpatient Billing and Payment Reimbursement Scenario

Table 02: Physician Billing and Payment for Reimbursement

Table 03: Key Mergers and Acquisitions

Table 04: Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 05: Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Condition, 2017–2027

Table 06: Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Medication Type, 2017–2027

Table 07: Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 08: Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 09: North America Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 10: North America Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 11: North America Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Condition, 2017?2027

Table 12: North America Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Medication Type, 2017?2027

Table 13: North America Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017?2027

Table 14: Europe Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 15: Europe Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 16: Europe Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Medication Type, 2017?2027

Table 17: Europe Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Condition, 2017?2027

Table 18: Europe Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017?2027

Table 19: Asia Pacific Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 20: Asia Pacific Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 21: Asia Pacific Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Condition, 2017?2027

Table 22: Asia Pacific Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Medication Type, 2017?2027

Table 23: Asia Pacific Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017?2027

Table 24: Latin America Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 25: Latin America Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 26: Latin America Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Condition, 2017?2027

Table 27: Latin America Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Medication Type, 2017?2027

Table 28: Latin America Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017?2027

Table 29: Middle East & Africa Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30: Middle East & Africa Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 31: Middle East & Africa Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Condition, 2017?2027

Table 32: Middle East & Africa Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Medication Type, 2017?2027

Table 33: Middle East & Africa Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017?2027